專案詳細資料
說明
This study provided novel knowledge about STING1-mediated cell death upon the treatment of PARP inhibitor. The combination of Olaparib and STING1 activators may enhance drug efficacy. In addition, targeting the STING1 pathway may serve as a novel therapeutic strategy to overcome Olaparib resistance.
| 狀態 | 已完成 |
|---|---|
| 有效的開始/結束日期 | 7/1/23 → 6/30/24 |
Keywords
- CRISPR基因編輯
- 去勢抗性攝護腺癌
- DNA修復
- 抗藥性
- 表觀基因調控
指紋
探索此專案觸及的研究主題。這些標籤是根據基礎獎勵/補助款而產生。共同形成了獨特的指紋。